SDZXF:OTCMKTS
Sandoz Group AG
84,03 $
0,00%
(0,00) 1D
23 қыр., 15:20:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZXF...
Mkt. cap
30,18 млрд
Avg. vol.
122,00
Volume
5,00
52-wk high
94,55 $
52-wk low
58,48 $
Shares outstanding
440,00 млн
No. of employees
20 мың
Mkt. cap
30,18 млрд
Avg. vol.
122,00
Volume
5,00
52-wk high
94,55 $
52-wk low
58,48 $
Shares outstanding
440,00 млн
No. of employees
20 мың
News stories
From web sources and news partners
GlobeNewswire
·
16 минут бұрын
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
16 минут бұрын
107 new hires got options to buy Knightscope shares; the options vest over four years.
Karyopharm
·
12 минут бұрын
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
48 минут бұрын
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG
CEORichard Saynor
Employees20 мың
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com